Clinical trial
Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine…
NCT00276445 · Meiji University of Oriental Medicine, Other · Terminated
Key facts
| NCT number | NCT00276445 |
|---|---|
| Title | Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan |
| Official title | Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan - A Double-Blind Randomized Study |
| Lead sponsor | Meiji University of Oriental Medicine, Other |
| Collaborators | Kyoto Prefectural University of Medicine |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | beta-1, 3-glucan |
| Enrollment | 60 |
| Start date | Jan 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Jan 13, 2006 |
| Last update posted | Nov 7, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: